Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 3Phase 1/2 2Phase NA 1

Status

Completed 4

Sponsor Class

NIH 9OTHER 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 2Genitourinary 1Breast 1

Conditions

Uveal Melanoma 2Melanoma 2Prostatic Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Interleukin-12 Subunit p35 × Clear all
NCT00004893 2016-07-19

Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
5 enrolled
Breast

Breast Neoplasms

NCT00003339 2014-05-22

Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma

University of Southern California

Phase 2 Completed
48 enrolled
Dermatologic

Uveal Melanoma, Melanoma

NCT00031733 2014-05-22

Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma

University of Southern California

Phase 2 Completed
60 enrolled
Dermatologic

Uveal Melanoma, Melanoma

NCT00015977 2014-03-07

Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

University of Chicago

Phase 2 Completed
13 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡